IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aridis Pharmaceuticals Inc (ARDS)

CUSIP: 040334104 | NYSE | Healthcare · Biotechnology | Micro Cap | 53 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q3 2025Q4 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/AArmistice Capital, LLC5,096,25111.4%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/AArmistice Capital, LLC5,096,251
11.4% of class · Jun 30, 2026New 5%+ stake
No 13F filer matched

Institutional Holders — Q3 2026

Strengthening Families & Communities, LLC3,000
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Strengthening Families & Communities, LLC
3,000$00.0%CoreMediumBoston, MA2026-10-21